Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4630s-4632s, September 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larouze, B.
Right arrow Articles by Levy, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larouze, B.
Right arrow Articles by Levy, J. P.

Antibodies to HTLV-I p24 in African and Portuguese Populations1

B. Larouze2, L. Schaffar-Deshayes, S. Blesonski, C. Gaudebout, J. M. Afoutou, P. Couillin, M. Da Graca Porto, L. Diakhate, M. L. Frelut, M. Jeddi, E. Mercier, F. Noireau, B. Nouasria, M. Ravaoarinoro and J. P. Levy

Institut de Médecine et d'Epidémiologie Tropicales/INSERM U13, Hôpital Claude Bernard, 75944 Paris Cédex 19, France [B. L., C. G.]; INSERM U152, Hôpital Cochin, 75014 Paris, France [L. S., S. B., J. P. L.]; INSERM U73, Château de Longchamps, 75016 Paris, France [P. C.]; Instituto de Ciencias Biomedicas, Universidade do Porto, Portugal [M. D. G. P.]; Faculté de Médecine de Dakar, Sénégal [J. M. A., L. D.]; Hôpital de Bangui, Central African Republic [M. L. F.]; Faculté de Pharmacie de Monastir Tunisia [M. J.]; Equipe Médicale de Tokora, Uganda [E. M.]; Office de la Recherche Scientifique et Technique Outre Mer, Brazzaville, the Congo [F. N.]; Service de pathologie infectieuse, Hôpital de Constantine, Algeria [B. N.]; Institut Pasteur de Tananarive, Madagascar [M. R.]

Using a radioimmunoassay to detect HTLV-I protein antibodies of molecular weight 24,000, we screened populations from Algeria (140 subjects), Tunisia (442), Mali (69), Senegal (415), Uganda (135), the Central African Republic (77), the Congo (360), and Madagascar (193). Only four subjects were positive (1 from Senegal, 1 from Uganda, 2 from the Congo). This is a much lower figure than that found by others in Africa by the enzyme-linked immunosorbent assay technique. In addition, 319 Portuguese blood donors (46 of whom have lived in Angola or Mozambique) were screened using the same radioimmunoassay. All were negative.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.